BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31227471)

  • 1. Lap Time Variability From a 400-m Walk Is Associated With Future Mild Cognitive Impairment and Alzheimer's Disease.
    Tian Q; Resnick SM; Studenski SA; Ferrucci L
    J Am Med Dir Assoc; 2019 Dec; 20(12):1535-1539.e3. PubMed ID: 31227471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Combined Slow Gait and Low Activity Fragmentation With Later Onset of Cognitive Impairment.
    Tian Q; Studenski SA; An Y; Kuo PL; Schrack JA; Wanigatunga AA; Simonsick EM; Resnick SM; Ferrucci L
    JAMA Netw Open; 2021 Nov; 4(11):e2135168. PubMed ID: 34792590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait speed or gait variability, which one to use as a marker of risk to develop Alzheimer disease? A pilot study.
    Gillain S; Dramé M; Lekeu F; Wojtasik V; Ricour C; Croisier JL; Salmon E; Petermans J
    Aging Clin Exp Res; 2016 Apr; 28(2):249-55. PubMed ID: 26076908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
    Kim MS; Yoon JH; Hong JM
    Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month change in gait speed to discriminate between those with and without falls history in older people with Mild Cognitive Impairment and mild Alzheimer disease.
    Masse FAA; Ansai JH; Gerassi RC; Tsen C; Cezar NOC; de Andrade LP
    Geriatr Nurs; 2022; 48():274-279. PubMed ID: 36335854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait variability at fast-pace walking speed: a biomarker of mild cognitive impairment?
    Beauchet O; Allali G; Launay C; Herrmann FR; Annweiler C
    J Nutr Health Aging; 2013 Mar; 17(3):235-9. PubMed ID: 23459976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective measurement of gait parameters in healthy and cognitively impaired elderly using the dual-task paradigm.
    König A; Klaming L; Pijl M; Demeurraux A; David R; Robert P
    Aging Clin Exp Res; 2017 Dec; 29(6):1181-1189. PubMed ID: 28130713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semantic and Phonemic Verbal Fluency Discrepancy in Mild Cognitive Impairment: Potential Predictor of Progression to Alzheimer's Disease.
    Vaughan RM; Coen RF; Kenny R; Lawlor BA
    J Am Geriatr Soc; 2018 Apr; 66(4):755-759. PubMed ID: 29572820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks.
    Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA
    Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive status, fast walking speed and walking speed reserve-the Gait and Alzheimer Interactions Tracking (GAIT) study.
    Callisaya ML; Launay CP; Srikanth VK; Verghese J; Allali G; Beauchet O
    Geroscience; 2017 Apr; 39(2):231-239. PubMed ID: 28374167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.